Kookjeon Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11,108	7,694	46,824	10,992	21,546	19,099
Short-Term Investments	-	5,166	-	15,000	45,000	20,160
Trading Asset Securities	19,278	17,689	-	38,840	28,425	-
Cash & Short-Term Investments	30,386	30,549	46,824	64,833	94,971	39,259
Cash Growth	-21.24%	-34.76%	-27.78%	-31.73%	141.91%	-
Accounts Receivable	27,823	23,291	28,779	26,850	21,923	20,015
Other Receivables	72.81	168.7	66.66	1,964	867.93	194.62
Receivables	28,366	23,860	29,255	29,065	23,403	20,409
Inventory	22,816	18,026	26,798	27,563	20,209	16,207
Prepaid Expenses	-	816.82	538.53	494.91	246.48	143.8
Other Current Assets	2,432	1,495	1,773	2,036	4,064	896.09
Total Current Assets	84,000	74,746	105,189	123,992	142,893	76,915
Property, Plant & Equipment	86,658	85,059	87,360	86,060	46,118	24,026
Long-Term Investments	4,355	4,335	5,322	4,364	3,173	3,493
Goodwill	420.39	420.39	420.39	420.39	420.39	-
Other Intangible Assets	886.51	903.17	908.17	971	903.51	422.37
Long-Term Deferred Tax Assets	3,471	3,048	2,185	1,964	-	794.9
Long-Term Deferred Charges	3,500	3,500	3,500	-	-	-
Other Long-Term Assets	5,406	7,035	7,169	7,090	2,379	517.79
Total Assets	188,787	179,207	212,273	225,102	196,097	106,989
Accounts Payable	17,067	11,887	17,833	11,693	9,474	10,989
Accrued Expenses	285.51	301.7	359.99	289.73	178.99	83.02
Short-Term Debt	21,604	27,164	37,461	15,224	7,883	5,133
Current Portion of Long-Term Debt	2,479	2,479	2,918	36,802	26,015	1,457
Current Portion of Leases	196.92	186.24	274.88	236.17	147.15	124.88
Current Income Taxes Payable	89.06	-	-	-	-	1,057
Current Unearned Revenue	-	-	-	35.16	-	-
Other Current Liabilities	22,097	24,059	29,729	35,542	26,993	3,007
Total Current Liabilities	63,818	66,076	88,576	99,823	70,691	21,852
Long-Term Debt	15,399	15,526	24,035	26,183	25,091	942.84
Long-Term Leases	510.63	546.79	622.23	334.14	202.84	193.97
Pension & Post-Retirement Benefits	-	-0	-0	-0	-0	-0
Long-Term Deferred Tax Liabilities	-	-	10.45	10.45	1,365	-
Other Long-Term Liabilities	1,188	1,185	1,529	1,296	6,425	849.76
Total Liabilities	80,916	83,335	114,774	127,646	103,774	23,838
Common Stock	5,399	5,018	4,907	4,907	4,907	4,907
Additional Paid-In Capital	78,317	65,713	62,139	62,386	62,386	62,397
Retained Earnings	22,923	25,585	30,375	29,129	24,305	15,848
Treasury Stock	-1.16	-1.16	-1.16	-1.16	-1.16	-1.16
Comprehensive Income & Other	-0	0	-0	0	0	0
Total Common Equity	106,638	96,314	97,420	96,422	91,597	83,150
Minority Interest	1,233	-442.06	79.38	1,035	725.74	-
Shareholders' Equity	107,871	95,872	97,499	97,456	92,323	83,150
Total Liabilities & Equity	188,787	179,207	212,273	225,102	196,097	106,989
Total Debt	40,189	45,902	65,312	78,780	59,339	7,852
Net Cash (Debt)	-9,803	-15,354	-18,488	-13,947	35,632	31,407
Net Cash Growth	-	-	-	-	13.45%	-
Net Cash Per Share	-195.09	-307.93	-372.69	-284.24	695.44	712.02
Filing Date Shares Outstanding	53.99	50.18	49.07	49.07	49.07	49.07
Total Common Shares Outstanding	53.99	50.18	49.07	49.07	49.07	49.07
Working Capital	20,182	8,670	16,613	24,169	72,202	55,063
Book Value Per Share	1975.28	1919.52	1985.36	1965.01	1866.70	1694.56
Tangible Book Value	105,331	94,991	96,091	95,030	90,274	82,728
Tangible Book Value Per Share	1951.07	1893.14	1958.28	1936.66	1839.72	1685.95
Land	21,734	20,724	20,224	19,837	15,613	3,997
Buildings	38,987	38,110	37,374	36,673	11,300	8,252
Machinery	32,696	31,886	30,220	22,297	11,051	7,554
Construction In Progress	574.56	362.65	624.1	6,407	13,388	9,214